RiboX’s China Trial Data Bought It an Accelerated Dose Titration and a Subcutaneous Route
RiboX filed its Chinese investigator-initiated data with the IND. FDA granted faster escalation and a subcutaneous route on the strength of it.
The Beats
Analysis
The Briefs
RiboX’s China Trial Data Bought It an Accelerated Dose Titration and a Subcutaneous Route
Imvanex Now Covers European Two-Year-Olds. The Children Carrying the Burden Are in Africa.
Replimune Won Accelerated Approval on 91 Evaluable Patients and a 24% Response Rate
Scholar Rock Filed With Two Fill-Finish Sites. One Just Failed, and the Date Held.
Tau does its damage inside mitochondria, independent of tangles and microtubules. The field’s imaging toolkit was built to see neither.